Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna dehns ltd
operating since 1920
1338.7
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 43 EP applications Rebecca Katherine Gardner has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12717826

METHODS FOR DETERMINING LIGAND BINDING TO A TARGET PROTEIN USING A THERMAL SHIFT ASSAY

IPC classification:
G01N 33/68
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12765926

ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF

IPC classification:
A61K 49/00, A61K 39/395, G01N 33/574, C12Q 1/02, C12N 15/13, C07K 16/46, C07K 16/30, C07K 16/18, A61P 35/04, A61P 35/00
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
PATENT GRANTED
EP12785487

STABLE ELECTRICALLY ACTIVE NEURONS FROM ADULT TISSUE

IPC classification:
C12N 5/071, C12M 1/34
Applicant:
University of Central Florida Research Foundation Inc
Agent:
Jobst Wibbelmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
PATENT GRANTED
EP12727398

METHOD FOR MICROBIAL CONTROL OF INJECTION LIQUID FLOW IN A HYDROCARBON RESERVOIR

IPC classification:
C12P 7/10, C09K 8/582
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP12792072

STRUCTURE FOR TISSUE REGENERATION AND A PRODUCTION METHOD THEREFOR

IPC classification:
A61L 27/38, C12N 5/0775
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP12782326

EFFECTIVE AMOUNTS OF (3AR)-1,3A,8-TRIMETHYL-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL PHENYLCARBAMATE AND METHODS THEREOF

IPC classification:
A61K 31/407, A01N 43/00, A61P 25/28
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12843112

GIGAXONIN FUSION PROTEIN AND METHODS FOR TREATING GIANT AXONAL NEUROPATHY

IPC classification:
A61K 38/17, C07K 19/00, A61P 25/00
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
The patent has been granted
EP12757224

SCREENING METHODS

IPC classification:
A01N 63/00, A01H 17/00, A01H 3/00
Agent:
Dr Nienke Lubben, HGF Limited
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP12784640

ADDITIVES FOR USE IN WOOD PRESERVATION

IPC classification:
A01N 59/16, A01N 33/12, A01N 25/30, A01N 59/20, B27K 3/22
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13700347

PEPTIDES AND PEPTIDE DERIVATIVES BASED ON XENIN

IPC classification:
A61K 38/17, C07K 14/47, A61P 3/10, A61P 3/04
Applicant:
University of Ulster
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
The patent has been granted
EP13700587

THERAPEUTIC BORON-CONTAINING COMPOUNDS

IPC classification:
A61K 31/69, C07F 5/02, A61P 31/10, A61P 31/06
Applicant:
University of Tromsø (Universitetet i Tromsø - Norges arktiske universitet)
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12777826

METHOD OF TREATING DYSKINESIA

IPC classification:
A61K 45/06, A61K 31/485, A61K 31/197, A61P 25/16, A61P 25/14
Applicant:
University of Medicine and Dentistry of New Jersey
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP12814985

COMBINATION TREATMENT FOR CANCER

IPC classification:
A61K 31/7068, A61K 31/704, A61K 31/65, A61K 31/473, A61K 31/136, A61P 35/02
Applicant:
University Health Network (UHN)
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
APPLICATION WITHDRAWN
EP12774693

FUSION PEPTIDE DESIGNED TO REDUCE PLAQUE BACTERIA AND YEAST IN THE ORAL CAVITY

IPC classification:
A61K 45/06, A61K 38/40, A61K 38/16, C07K 14/79, C07K 14/21, A61P 31/04
Applicant:
University of Medicine and Dentistry of New Jersey - Office of Technology Transfer and Business Development
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
PATENT GRANTED
EP13705249

ENDONUCLEASES

IPC classification:
C12Q 1/68, C12N 9/99, C12N 9/22
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
PATENT GRANTED
EP13751181

CO-USE OF A CLUSTERIN INHIBITOR WITH AN EGFR INHIBITOR TO TREAT CANCER

IPC classification:
A61K 39/395, A61K 31/5377, A61P 35/00
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13179983

Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents

IPC classification:
A61P 25/28, A61K 31/4045, C07C 317/36, C07C 255/58, C07C 225/22, C07D 209/14, C07D 209/16
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13794110

DIABETES BIOMARKERS

IPC classification:
A61K 45/00, G01N 33/48, A61P 37/00, A61P 5/50
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13810575

CTLA4 FUSION PROTEINS FOR THE TREATMENT OF DIABETES

IPC classification:
A61K 38/17, C07K 14/705, C07K 14/47, A61P 3/10
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP13819634

ANTI-SIGLEC-15 ANTIBODIES

IPC classification:
A61K 39/395, C12N 15/85, C12N 15/13, C12N 5/10, C07K 16/28, A61P 19/08
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
William Gerrit Arends, Marks & Clerk
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13810467

COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES

IPC classification:
A61K 39/00, A61K 38/19, A61P 3/10
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13838538

METHODS OF SCREENING FOR MICROORGANISMS THAT IMPART BENEFICIAL PROPERTIES TO PLANTS

IPC classification:
A01H 3/00, C12N 1/20
Agent:
Dr Nienke Lubben, HGF Limited
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP14200660

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

IPC classification:
A61K 38/00
Applicant:
University of Utah Research Foundation
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
EXAMINATION IN PROGRESS
EP13818771

BIOMARKERS IN INFLAMMATORY BOWEL DISEASE

IPC classification:
G01N 33/68, G01N 33/50
Applicant:
University of Tromsø (Universitetet i Tromsø - Norges arktiske universitet)
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP14701757

ASSESSING CIRCULATORY FAILURE

IPC classification:
A61B 5/1455, A61B 5/026, A61B 5/00, G01N 21/49
Applicant:
Oslo University Hospital HF (Oslo Universitetssykehus HF)
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP11861479

METHODS AND COMPOSITIONS COMPRISING IL-7 RECEPTOR LIGANDS

IPC classification:
C12N 15/24, C07K 14/54
Applicant:
University of Central Florida Research Foundation Inc
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14837396

METHODS AND COMPOSITIONS FOR CDNA SYNTHESIS AND SINGLE-CELL TRANSCRIPTOME PROFILING USING TEMPLATE SWITCHING REACTION

IPC classification:
C07H 21/04, C12P 19/34
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP14826457

WHOLE-GENOME AND TARGETED HAPLOTYPE RECONSTRUCTION

IPC classification:
C12Q 1/68
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP16168125

ADDITIVES FOR USE IN WOOD PRESERVATION

IPC classification:
A01N 33/12, A01N 25/30, B27K 3/22, A01N 59/20, A01N 59/16
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
APPLICATION PUBLISHED
EP15703957

NEURODEGENERATIVE THERAPIES

IPC classification:
A61P 25/28, A61K 31/428
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP15703272

ANTI-LYMPHOMA PEPTIDES

IPC classification:
C07K 7/08, C07K 7/06, A61K 39/00
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP15749291

HYBRID PROTEINS AND USES THEREOF

IPC classification:
C12P 21/02, C12N 5/10, C12N 15/87, C12N 15/85, C12N 15/63, C12N 15/62, C12N 1/21, C07K 14/435, C07K 14/16, C07K 14/025, C07K 19/00
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP15713749

ANTIBODIES AGAINST HPA-1a

IPC classification:
C07K 16/28
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
EXAMINATION REQUESTED
EP16171408

ANTIBODIES THAT SPECIFICALLY BLOCK THE BIOLOGICAL ACTIVITY OF A TUMOR ANTIGEN

IPC classification:
A61K 48/00, G01N 33/574, C07K 16/30, C07K 16/18, A61K 39/395, A61K 39/00, A61K 31/7088, C12N 15/13
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP16190193

ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF

IPC classification:
G01N 33/574, C12Q 1/02, C12N 15/13, C07K 16/46, C07K 16/18, A61P 35/04, A61P 35/00, A61K 49/00, A61K 39/395, C07K 16/30
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP15843249

TREATMENT OF RETT SYNDROME

IPC classification:
C07F 9/38
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP16203468

POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER

IPC classification:
C07K 14/47, A61P 35/00, A61K 39/395
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP15793746

IMMUNE CHECKPOINT INHIBITOR COMBINATIONS

IPC classification:
A61K 38/08, C07K 16/28
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP15793749

CHEMOTHERAPEUTIC COMBINATIONS OF CATIONIC ANTIMICROBIAL PEPTIDES AND CHEMOTHERAPEUTICS

IPC classification:
A61P 35/00, A61K 31/704, A61K 31/675, A61K 45/06, A61K 38/08
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP16759200

OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREFOR

IPC classification:
A61P 27/02, A61P 27/10, C07K 14/495, A61K 31/573
Applicant:
Auckland Uniservices Limited
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP16785690

COMPOSITIONS AND METHODS FOR ADMINISTERING ANTIBODIES

IPC classification:
B82Y 5/00, A61P 17/02, A61K 39/44, A61K 9/14
Applicant:
University of South Australia
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP16733924

RESERVOIR TREATMENTS

IPC classification:
E21B 33/138, C09K 8/582, C09K 8/516, C09K 8/42
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made
EP16750443

HYPERPHENYLALANINEMIA AND TREATMENTS THEREOF

IPC classification:
A61P 3/00, A61K 45/06, A61K 31/519, A61K 31/506, A61K 31/505, A61K 31/44
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
Request for examination was made

Please Sign in to use this feature